Sign in

CIK 0001563665

  • Non-accelerated filer
  • Smaller reporting company

Harvard Apparatus Regenerative Technology, Inc.

Sign in to watch
Ticker
HRGN
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455210462
Phone
+1 774-233-7300
Business address
84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
Former names
Biostage, Inc.
  1. 4 Open-market buy 10% owner bought 8,700 shares at an average $2.37 ($20,620)
  2. 4 Open-market buy 10% owner bought 5,200 shares at an average $2.15 ($11,180)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy President and CMO bought 100,000 shares at $0.37 ($37,000)
  5. 4 Open-market buy President and CMO bought 150,000 shares at $0.32 ($48,000)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.91 ($9,100)
  14. 4 Open-market buy Director bought 16,182 shares at $0.93 ($15,033)
  15. 4 Open-market buy President and CEO bought 25,000 shares at $0.96 ($24,000)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy President and CEO bought 20,000 shares at $1.07 ($21,400)
  18. 4 Open-market buy Director bought 32,000 shares at $1.17 ($37,475)
  19. 4 Open-market buy Director bought 17,241 shares at $1.46 ($25,172)
  20. 4 Open-market buy Director bought 6,500 shares at $1.56 ($10,139)

Page 8 of 12 · 235 filings